May 28, 2026 08:05AM
May 28, 2026 08:05AM
May 27, 2026 08:05AM
May 27, 2026 08:05AM
May 13, 2026 08:07AM
May 13, 2026 08:05AM
May 6, 2026 08:10AM Aptevo reports 87% clinical benefit rate in frontline AML trial
May 6, 2026 08:05AM
Mar 26, 2026 08:05AM
Mar 19, 2026 08:05AM
Mar 10, 2026 08:21AM
Mar 10, 2026 08:05AM
Feb 3, 2026 08:06AM
Feb 3, 2026 08:05AM Aptevo Announces Executive Leadership Transitions to Support Next Phase of Growth
Jan 28, 2026 04:23PM
Jan 9, 2026 08:05AM
Jan 9, 2026 08:05AM
Dec 26, 2025 08:05AM
Dec 26, 2025 08:05AM
Dec 9, 2025 08:07AM
Dec 9, 2025 08:05AM Aptevo Therapeutics Highlights Compelling Safety and Strong Remission Rates for Mipletamig in Frontline AML at ASH 2025
Nov 10, 2025 08:05AM
Nov 10, 2025 08:05AM
Nov 6, 2025 08:05AM
Oct 8, 2025 08:20AM
Oct 1, 2025 04:34PM
Sep 16, 2025 08:34AM
Sep 16, 2025 08:30AM Mipletamig Delivers 100% Remission Rate in Cohort 3 of RAINIER Trial for AML
Sep 5, 2025 09:00AM
Sep 4, 2025 08:46AM
Sep 4, 2025 08:45AM
Aug 13, 2025 08:06AM
Aug 13, 2025 08:05AM
Aug 11, 2025 10:53AM
Aug 11, 2025 08:05AM Aptevo Therapeutics Reports 2Q25 Financial Results And Provides A Business Update
Aug 8, 2025 09:00AM
Jul 25, 2025 04:18PM
Jun 20, 2025 11:30AM
Jun 20, 2025 11:30AM
Jun 20, 2025 08:55AM
Jun 20, 2025 08:55AM
Jun 18, 2025 10:53AM Aptevo Therapeutics (APVO) Halted on Volatility, Off Highs Following Offering
Jun 18, 2025 10:52AM
Jun 18, 2025 10:52AM
Jun 18, 2025 08:07AM
Jun 18, 2025 08:01AM
Jun 13, 2025 08:05AM
May 22, 2025 08:11AM
May 22, 2025 08:05AM Aptevo Therapeutics Announces 1-for-20 Reverse Stock Split as part of Nasdaq Compliance Plan
May 15, 2025 08:07AM

413,489 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All